NextCure, Inc. IPO Research Information

NextCure, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on NextCure, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
NextCure, Inc.	NXTC - NASDAQ	$14.00-$16.00	$15.00	$15.55	5 million	5/9/2019
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2019-04-12 Terms Added 2019-04-29

NextCure, Inc. Quote & Chart - Click for current quote - NXTC

About NextCure, Inc. (adapted from NextCure, Inc. prospectus):
They are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NXTC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.